https://www.selleckchem.com/pr....oducts/Gefitinib.htm
We investigated the impact of ceasing routine falls risk assessment tool (FRAT) completion and instead used clinical reasoning to select fall mitigation strategies. Two-group, multi-site cluster-randomized active-control non-inferiority trial. Hospital wards. Adult inpatients admitted to participating hospitals (n = 10 hospitals, 123,176 bed days). Hospitals were randomly assigned (11) to a usual care control group that continued to use a historical FRAT to assign falls risk scores and accompanying mitigation strategies, or an experim
Curtir
Comentario
Compartilhar
